Evidence map›Paper›PMID 42758192›Full record

ReviewWorld journal of urology2026

The role of urodynamics in overactive bladder: a critical in-depth analysis of the FUTURE study.

Claire Hentzen, Benoit Peyronnet, Maurizio Serati, Tufan Tarcan, Thomas M Kessler, Eskinder Solomon, Ruth Kirschner-Hermanns, Cosimo De Nunzio, Enrico Finazzi-Agro

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Claire HentzenSorbonne University, GRC 01, GREEN Group of clinical REsEarch in Neurourology, AP- HP, Hôpital Pitié Salpêtrière, F-75013, Paris, France. claire.hentzen@aphp.fr.ORCID http://orcid.org/0000-0002-9223-4925
Benoit PeyronnetUniversity Hospital of Rennes, Rennes, France.
Maurizio SeratiDepartment of Obstetrics and Gynaecology, Del Ponte Hospital, University of Insubria, Varese, Italy.
Tufan TarcanDepartment of Urology, Marmara University School of Medicine, Istanbul Türkiye &, Koç University School of Medicine, Istanbul, Türkiye.
Thomas M KesslerDepartment of Neuro-Urology, Spinal Cord Injury Center, Balgrist University Hospital, University of Zürich, Zürich, Switzerland.
Eskinder SolomonGuy's and St Thomas NHS Foundation Trust, London, UK.
Ruth Kirschner-HermannsUniversity Clinic, Neuro-Urology Johanniter Neurologic Rehabilitation Center, Bonn, Bad Godesberg, Germany.
Cosimo De NunzioSapienza University of Rome, Ospedale Sant'Andrea, Rome, Italy.
Enrico Finazzi-AgroDept. of Surgical Sciences, University of Rome Tor Vergata and UOSD Urologia, Policlinico Tor Vergata Hospital, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The FUTURE study, a large randomised controlled trial in women with refractory overactive bladder, concluded that urodynamics does not improve outcomes when added to clinical assessment and is not cost-effective. These findings have been presented as justification for abandoning urodynamics in this large and heterogeneous patient population. In this paper, we undertake a detailed appraisal of the FUTURE study, examining its overarching research premise, the design and methodology it employed to evaluate the clinical utility of urodynamics and the way in which its findings were reported and interpreted by the authors. We conclude that significant conceptual and methodological limitations undermine the validity of the study and the reliability and generalisability of the data. Consequently, changes in clinical practice are not justified on the basis of the FUTURE study.

Indexed as

Urinary Bladder, OveractiveUrodynamicsFemaleHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.